Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RDG-17012 vs Pradaxa PK/Safety Study
NCT03495739Phase 1Unknown
- Sponsor
- Huons
- Start
- Feb 2018
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of RDG-17012 in thromboembolism (2 arms), sponsored by Huons. Primary endpoints: Area Under Curve last of Total dabigatran and Free dabigatran at Day 2 and Maximum concentration of Total dabigatran and Free dabigatran at Day 2. Status: unknown.
02
Drugs
RDG-17012
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT03495739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03495739.